Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
The Prognostic Value of lncRNAs Expression and Clinicopathological Feature in Gastric Cancer: A Field Synopsis of Observational Studies
28 Pages Posted: 2 Oct 2018
More...Abstract
Background: Data on prognostic value of long non-coding RNAs (lncRNAs) to sporadic gastric cancer have been published at a growing pace. However, there has been no comprehensive quantitative overview has been available. We aim to investigate the association between the expression of long non-coding RNAs (lncRNAs), clinicopathological factors and prognosis of gastric cancer.
Methods: We explored correlation of lncRNA with clinicopathological features and prognosis. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS), disease-free survival (DFS)/progression-free survival (PFS)/Disease Specific Survival (DSS)/recurrence-free survival (RFS) were calculated to estimate the association strength.
Results: Literature search identified 80 eligible studies comprising 2205 cases which investigated senven gastric cancer associated clinicopathological factors. Overall, a significant association was observed between high lncRNAs level and poor OS in patients with gastric cancer (HR = 1.46, 95% CI: 1.31-1.63, P<0.001). We conduct stratified analysis based on statistical approach showing that high expression of lncRNAs in both log rank (HR=1.64, 95%CI: 1.32-2.03, P<0.001) and multivariate analysis (HR=1.37, 95%CI: 1.21-1.55, P<0.001) were significant associated with poor OS, and the pooled HR of association between elevated lncRNAs expression level and DFS/PFS/DSS/RFS in gastric cancer patients was 1.60 (95% CI: 1.29-1.98, P<0.001). For the OS, the results showed that the lncRNA expression level was signifcantly associated the clinicopathological parameters including TNM stage (P<0.001), tumor size (P<0.001), pathological differention (P=0.02), lymph nodes metastasis (P<0.001), distance metastasis (P<0.001) and invasion depth (P<0.001), and there was significant association in TNM stage (P<0.001), lymph nodes metastasis (P<0.001), distance metastasis (P<0.001), and invasion depth (P=0.02) for DFS.
Conclusion: High expression of lncRNA could predict poor prognosis in gastric cancer, and abnormal expression of lncRNAs supported the clinical value regarding the clinicopathological factors.
Funding: This study was funded by National Natural Science Foundation of China (81701536, 81373097).
Declaration of Interest: The authors declare no conflict of interest.
Keywords: ncRNA; clinicopathological factors; prognosis; gastric cancer; field synopsis
Suggested Citation: Suggested Citation